Cart is empty Some older people struggle with remembering to take their medications or organizing them effectively. Adult children, like yourself, can help by taking steps to monitor and update medication lists. Doing this can help prevent potential health complications, while also providing peace of mind for both you and your mom.
Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma
Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine say a new combination of antibody therapies produced a “surprisingly high” response rate in patients with high-risk follicular lymphoma, a type of non-Hodgkin lymphoma.
Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients
CAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even for patients regarded as high risk due to comorbidities.
Patients with common form of acute myeloid leukemia report better quality of life when treated with quizartinib
In a study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, patients recently diagnosed with a common and aggressive form of acute myeloid leukemia reported having improved quality of life when a newly approved drug was part of the treatment plan.
New drug helps narrow racial survival disparity in patients with acute myeloid leukemia: Study
Non-Hispanic Black patients with acute myeloid leukemia (AML) are living longer, now that new therapies are available, according to a study presented by researchers from the University of Pennsylvania Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition.
Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial
The Malaghan Institute of Medical Research, in collaboration with Wellington Zhaotai Therapies Limited, today announced results of its phase 1 dose escalation trial of a new third generation anti-CD19 chimeric antigen receptor (CAR) T-cell therapy to be presented at the American Society of Hematology (ASH) Annual Meeting in San Diego on 11 December. The research is also published in the journal Blood.
Risk of dying from cancer in some poorer districts of England over 70% higher than wealthy districts, study suggests
The risk of dying from the 10 forms of cancer with the largest death toll for men and women varies massively depending on the district in England where people live, according to a study published in The Lancet Oncology.
Guidance for prevention, diagnosis, evaluation, treatment of hepatitis C virus in chronic kidney disease
The latest clinical practice guideline from the Kidney Disease: Improving Global Outcomes (KDIGO) organization offers guidance for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) in chronic kidney disease (CKD).
Study reports progress in long-term protection against ovarian cancer tumors
Investigators from the C.S. Mott Center for Human Growth and Development at the Wayne State University School of Medicine reported today in Cancer Immunology Research the characterization of a novel therapeutic approach capable of restoring immune surveillance and providing long-term protection against ovarian cancer tumors.
Inclusive content, peer support, media information literacy can combat health misinformation spread on social media
Social media has become one of the main sources of information for youth, a population that on average engages with platforms such as TikTok and Instagram for nearly five hours per day.